Prevention of Iron Deficiency Anemia Post-delivery

Inclusion Criteria: * Established pregnancy \>20 weeks gestation by LMP and/or clinical assessment and/ Or USG * Age: 15 years (or lower limit age eligible\*) to 49 years * Confirmed moderate anemia (Hb 7.0 to 9.9 g/dL, 6-48 hour after delivery based on a venous blood sample on Hemocue®) * Deliver in participating study hospital or health facility * Able to provide informed consent * Plans to remain in study area for duration of the study Exclusion Criteria: * IV Iron infusion received in past 3 weeks * Contraindication to iron supplementation (some examples may include hemolytic anemia, allergy, severe infection) * Blood transfusion already received or scheduled during the current hospital admission * Known diagnosis of pre-existing depression or other psychiatric illness * Stillbirth, major congenital anomaly, or neonatal loss prior to randomization * Women testing positive and previously untreated for malaria * Presenting with symptomatic anemia with dyspnea or fatigue and need for immediate correction * Women with known hemoglobinopathy (sickle cell disease or thalassemia) * Presence of severe allergic conditions such as severe asthma or known drug allergies * Women presenting with any illness/condition requiring immediate medical care per physician's assessment